547 related articles for article (PubMed ID: 33172978)
1. Legumain Induces Oral Cancer Pain by Biased Agonism of Protease-Activated Receptor-2.
Tu NH; Jensen DD; Anderson BM; Chen E; Jimenez-Vargas NN; Scheff NN; Inoue K; Tran HD; Dolan JC; Meek TA; Hollenberg MD; Liu CZ; Vanner SJ; Janal MN; Bunnett NW; Edgington-Mitchell LE; Schmidt BL
J Neurosci; 2021 Jan; 41(1):193-210. PubMed ID: 33172978
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain.
Zhao P; Lieu T; Barlow N; Sostegni S; Haerteis S; Korbmacher C; Liedtke W; Jimenez-Vargas NN; Vanner SJ; Bunnett NW
J Biol Chem; 2015 May; 290(22):13875-87. PubMed ID: 25878251
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin S causes inflammatory pain via biased agonism of PAR2 and TRPV4.
Zhao P; Lieu T; Barlow N; Metcalf M; Veldhuis NA; Jensen DD; Kocan M; Sostegni S; Haerteis S; Baraznenok V; Henderson I; Lindström E; Guerrero-Alba R; Valdez-Morales EE; Liedtke W; McIntyre P; Vanner SJ; Korbmacher C; Bunnett NW
J Biol Chem; 2014 Sep; 289(39):27215-27234. PubMed ID: 25118282
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase D and Gβγ mediate sustained nociceptive signaling by biased agonists of protease-activated receptor-2.
Zhao P; Pattison LA; Jensen DD; Jimenez-Vargas NN; Latorre R; Lieu T; Jaramillo JO; Lopez-Lopez C; Poole DP; Vanner SJ; Schmidt BL; Bunnett NW
J Biol Chem; 2019 Jul; 294(27):10649-10662. PubMed ID: 31142616
[TBL] [Abstract][Full Text] [Related]
5. Protein Kinase D and Gβγ Subunits Mediate Agonist-evoked Translocation of Protease-activated Receptor-2 from the Golgi Apparatus to the Plasma Membrane.
Jensen DD; Zhao P; Jimenez-Vargas NN; Lieu T; Gerges M; Yeatman HR; Canals M; Vanner SJ; Poole DP; Bunnett NW
J Biol Chem; 2016 May; 291(21):11285-99. PubMed ID: 27030010
[TBL] [Abstract][Full Text] [Related]
6. Chronic compression or acute dissociation of dorsal root ganglion induces cAMP-dependent neuronal hyperexcitability through activation of PAR2.
Huang ZJ; Li HC; Cowan AA; Liu S; Zhang YK; Song XJ
Pain; 2012 Jul; 153(7):1426-1437. PubMed ID: 22541444
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of the proinflammatory and pronociceptive actions of canonical and biased agonists of protease-activated receptor-2.
Lieu T; Savage E; Zhao P; Edgington-Mitchell L; Barlow N; Bron R; Poole DP; McLean P; Lohman RJ; Fairlie DP; Bunnett NW
Br J Pharmacol; 2016 Sep; 173(18):2752-65. PubMed ID: 27423137
[TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cepsilon- and A-dependent mechanisms in rats and mice.
Amadesi S; Cottrell GS; Divino L; Chapman K; Grady EF; Bautista F; Karanjia R; Barajas-Lopez C; Vanner S; Vergnolle N; Bunnett NW
J Physiol; 2006 Sep; 575(Pt 2):555-71. PubMed ID: 16793902
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin S Evokes PAR
Tu NH; Inoue K; Chen E; Anderson BM; Sawicki CM; Scheff NN; Tran HD; Kim DH; Alemu RG; Yang L; Dolan JC; Liu CZ; Janal MN; Latorre R; Jensen DD; Bunnett NW; Edgington-Mitchell LE; Schmidt BL
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572924
[TBL] [Abstract][Full Text] [Related]
10. Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome.
Jimenez-Vargas NN; Pattison LA; Zhao P; Lieu T; Latorre R; Jensen DD; Castro J; Aurelio L; Le GT; Flynn B; Herenbrink CK; Yeatman HR; Edgington-Mitchell L; Porter CJH; Halls ML; Canals M; Veldhuis NA; Poole DP; McLean P; Hicks GA; Scheff N; Chen E; Bhattacharya A; Schmidt BL; Brierley SM; Vanner SJ; Bunnett NW
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):E7438-E7447. PubMed ID: 30012612
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia.
Amadesi S; Nie J; Vergnolle N; Cottrell GS; Grady EF; Trevisani M; Manni C; Geppetti P; McRoberts JA; Ennes H; Davis JB; Mayer EA; Bunnett NW
J Neurosci; 2004 May; 24(18):4300-12. PubMed ID: 15128844
[TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain state.
Tillu DV; Hassler SN; Burgos-Vega CC; Quinn TL; Sorge RE; Dussor G; Boitano S; Vagner J; Price TJ
Pain; 2015 May; 156(5):859-867. PubMed ID: 25734998
[TBL] [Abstract][Full Text] [Related]
13. Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice.
Grant AD; Cottrell GS; Amadesi S; Trevisani M; Nicoletti P; Materazzi S; Altier C; Cenac N; Zamponi GW; Bautista-Cruz F; Lopez CB; Joseph EK; Levine JD; Liedtke W; Vanner S; Vergnolle N; Geppetti P; Bunnett NW
J Physiol; 2007 Feb; 578(Pt 3):715-33. PubMed ID: 17124270
[TBL] [Abstract][Full Text] [Related]
14. The C-terminus of murine S100A9 protein inhibits hyperalgesia induced by the agonist peptide of protease-activated receptor 2 (PAR2).
Dale CS; Cenac N; Britto LR; Juliano MA; Juliano L; Vergnolle N; Giorgi R
Br J Pharmacol; 2006 Oct; 149(4):374-84. PubMed ID: 16967049
[TBL] [Abstract][Full Text] [Related]
15. The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo.
Grace MS; Lieu T; Darby B; Abogadie FC; Veldhuis N; Bunnett NW; McIntyre P
Br J Pharmacol; 2014 Aug; 171(16):3881-94. PubMed ID: 24779362
[TBL] [Abstract][Full Text] [Related]
16. Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer-associated fibroblasts by paracrine activation of protease-activated receptor 2.
Kanemaru A; Yamamoto K; Kawaguchi M; Fukushima T; Lin CY; Johnson MD; Camerer E; Kataoka H
Int J Cancer; 2017 Jan; 140(1):130-141. PubMed ID: 27615543
[TBL] [Abstract][Full Text] [Related]
17. Serine proteases and protease-activated receptor 2 mediate the proinflammatory and algesic actions of diverse stimulants.
Cattaruzza F; Amadesi S; Carlsson JF; Murphy JE; Lyo V; Kirkwood K; Cottrell GS; Bogyo M; Knecht W; Bunnett NW
Br J Pharmacol; 2014 Aug; 171(16):3814-26. PubMed ID: 24749982
[TBL] [Abstract][Full Text] [Related]
18. Protease-activated receptor-2 signaling through β-arrestin-2 mediates Alternaria alkaline serine protease-induced airway inflammation.
Yee MC; Nichols HL; Polley D; Saifeddine M; Pal K; Lee K; Wilson EH; Daines MO; Hollenberg MD; Boitano S; DeFea KA
Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L1042-L1057. PubMed ID: 30335499
[TBL] [Abstract][Full Text] [Related]
19. Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice.
Kume M; Ahmad A; DeFea KA; Vagner J; Dussor G; Boitano S; Price TJ
J Pain; 2023 Nov; 24(11):1980-1993. PubMed ID: 37315729
[TBL] [Abstract][Full Text] [Related]
20. C781, a β-Arrestin Biased Antagonist at Protease-Activated Receptor-2 (PAR2), Displays in vivo Efficacy Against Protease-Induced Pain in Mice.
Kume M; Ahmad A; Shiers S; Burton MD; DeFea KA; Vagner J; Dussor G; Boitano S; Price TJ
J Pain; 2023 Apr; 24(4):605-616. PubMed ID: 36417966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
